Olpasiran, Placebo for AMG 890
20230191
Phase 3 small_molecule active
Quick answer
Olpasiran, Placebo for AMG 890 for Cardiovascular Disease is a Phase 3 program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Cardiovascular Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active